These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 9260171)

  • 1. The economic and social costs of drug abuse among the rural population.
    Donnermeyer JF
    NIDA Res Monogr; 1997; 168():220-45. PubMed ID: 9260171
    [No Abstract]   [Full Text] [Related]  

  • 2. Economic costs of drug abuse: financial, cost of illness, and services.
    Cartwright WS
    J Subst Abuse Treat; 2008 Mar; 34(2):224-33. PubMed ID: 17596904
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Estimating the economic costs of the abuse of tobacco, alcohol and illicit drugs: a review of methodologies and Canadian data sources.
    Choi BC; Robson L; Single E
    Chronic Dis Can; 1997; 18(4):149-65. PubMed ID: 9445363
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Social determinates of health: focus on substance use and abuse.
    Malliarakis KD; Lucey P
    Nurs Econ; 2007; 25(6):368-70, 375. PubMed ID: 18240840
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A critical review of accounting and economic methods for estimating the costs of addiction treatment.
    Cartwright WS
    J Subst Abuse Treat; 2008 Apr; 34(3):302-10. PubMed ID: 17614244
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Costs of alcohol and drug abuse in the United States, 1992. Alcohol/Drugs COI Study Team.
    Holland P; Mushinski M
    Stat Bull Metrop Insur Co; 1999; 80(4):2-9. PubMed ID: 10553265
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Guidelines and challenges for estimating the economic costs and benefits of adolescent substance abuse treatments.
    Zavala SK; French MT; Henderson CE; Alberga L; Rowe C; Liddle HA
    J Subst Abuse Treat; 2005 Oct; 29(3):191-205. PubMed ID: 16183468
    [TBL] [Abstract][Full Text] [Related]  

  • 8. How the staggering costs of substance abuse add up to billions of $$.
    Smith M; Freeman RA
    Pharm Times; 1983 May; 49(5):78-83. PubMed ID: 10317329
    [No Abstract]   [Full Text] [Related]  

  • 9. A research agenda for economic evaluation of substance abuse services.
    French MT; Drummond M
    J Subst Abuse Treat; 2005 Sep; 29(2):125-37. PubMed ID: 16135341
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Managed care, networks and trends in hospital care for mental health and substance abuse treatment in Massachusetts: 1994-1999.
    Fleming E; Lien H; Ma CT; McGuire TG
    J Ment Health Policy Econ; 2003 Mar; 6(1):3-12. PubMed ID: 14578543
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Organizational and client determinants of cost in outpatient substance abuse treatment.
    Beaston-Blaakman A; Shepard D; Horgan C; Ritter G
    J Ment Health Policy Econ; 2007 Mar; 10(1):3-13. PubMed ID: 17417043
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New federally funded study estimates total cost of alcohol and drug abuse at $246 billion in 1992.
    Psychiatr Serv; 1998 Aug; 49(8):1110. PubMed ID: 9712228
    [No Abstract]   [Full Text] [Related]  

  • 13. Why we should still estimate the costs of substance abuse even if we needn't pay undue attention to the bottom line.
    Single E
    Drug Alcohol Rev; 2009 Mar; 28(2):117-21. PubMed ID: 19320695
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Economic analysis of costs and consequences of the treatment of drug misuse: 2-year outcome data from the National Treatment Outcome Research Study (NTORS).
    Godfrey C; Stewart D; Gossop M
    Addiction; 2004 Jun; 99(6):697-707. PubMed ID: 15139868
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Polydrug abuse in heroin addicts: a behavioral economic analysis.
    Glautier S
    Addiction; 1998 Apr; 93(4):603-4; discussion 605-6. PubMed ID: 9696618
    [No Abstract]   [Full Text] [Related]  

  • 16. Are calculations of the economic costs of drug abuse either possible or useful?
    Reuter P
    Addiction; 1999 May; 94(5):635-8. PubMed ID: 10563026
    [No Abstract]   [Full Text] [Related]  

  • 17. Outcomes and costs of matching the intensity of dual-diagnosis treatment to patients' symptom severity.
    Chen S; Barnett PG; Sempel JM; Timko C
    J Subst Abuse Treat; 2006 Jul; 31(1):95-105. PubMed ID: 16814015
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cost-effectiveness analysis of integrated care for people with HIV, chronic mental illness and substance abuse disorders.
    Weaver MR; Conover CJ; Proescholdbell RJ; Arno PS; Ang A; Uldall KK; Ettner SL
    J Ment Health Policy Econ; 2009 Mar; 12(1):33-46. PubMed ID: 19346565
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effectiveness and benefit-cost of peer-based workplace substance abuse prevention coupled with random testing.
    Miller TR; Zaloshnja E; Spicer RS
    Accid Anal Prev; 2007 May; 39(3):565-73. PubMed ID: 17125723
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Economic benefits of substance abuse treatment: findings from Cuyahoga County, Ohio.
    Koenig L; Siegel JM; Harwood H; Gilani J; Chen YJ; Leahy P; Stephens R
    J Subst Abuse Treat; 2005; 28 Suppl 1():S41-50. PubMed ID: 15797638
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.